Dr. Lawenda recommends to assessing and tracking insulin resistance and systemic inflammation biomarkers, which are associated with the development, progression and mortality from numerous chronic diseases and cancer.
Do you have insulin resistance? Most people don’t know, but the adult U.S. population overall risk of being metabolically unhealthy is up to 88%. Having insulin resistance increases one’s risk of cancer development and progression, cardiovascular disease, diabetes and dementia. Get tested.
Once you discover if you have insulin resistance or systemic inflammation, you can address these issues and track your progress over time.